At AAPS PharmSci 360 2025, held from Nov. 9–12 in San Antonio, Texas, Corey Bloom, PhD, associate director, CMC (chemistry, manufacturing, and controls) and Bioavailability Enhancement at
Here, Bloom answers some questions about key points in his talk at the conference.
How important is selecting the appropriate drug delivery technology to address low solubility compounds?
Today, compounds with low solubility or low bioavailability are becoming the rule rather than the norm,…